PuSH - Publication Server of Helmholtz Zentrum München

163 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Bartenschlager, R.* ; Urban, S.* & Protzer, U.: Towards curative therapy of chronic viral hepatitis. Z. Gastroenterol. 57, 61-73 (2019)
2.
Bockmann, J.H. et al.: Comparative analysis of the antiviral effects mediated by type I and III interferons in hepatitis B virus infected hepatocytes. J. Infect. Dis., accepted (2019)
3.
Festag, M. et al.: Evaluation of a fully human, hepatitis B virus-specific chimeric antigen receptor in an immunocompetent mouse model. Mol. Ther. 27, 947-959 (2019)
4.
Karimzadeh, H. et al.: Mutations in hepatitis D virus allow it to escape detection by CD8+ T cells and evolve at the population level. Gastroenterology 156, 1820-1833 (2019)
5.
Oberhardt, V.* et al.: Viral escape contributes to the failure of hepatitis D virus-specific CD8+T-cells and drives evolution of HDV. J. Hepatol. 70, E21-E21 (2019)
6.
Schreiber, S. et al.: Characterization of a library of CD4+T cells for T-cell therapy of HBV infection. J. Hepatol. 70, E456-E456 (2019)
7.
Su, J. et al.: Exploring TH1/TH2 adjuvants to improve the efficacy of the therapeutic vaccination against chronic hepatitis B. J. Hepatol. 70, E485-E486 (2019)
8.
Velkov, S. ; Protzer, U. & Michler, T.: Approximation of the genotype distribution within global chronic hepatitis B virus infections. J. Hepatol. 70, E711-E711 (2019)
9.
Wing, P.A.* et al.: A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis. Life Sci. All. 2:e201900355 (2019)
10.
Wisskirchen, K.* et al.: T cell receptor grafting allows virological control of Hepatitis B virus infection. J. Clin. Invest. 130, accepted (2019)
11.
Burwitz, B.J.* et al.: A new HIV/HBV co-infection model: Hepatocytic expression of human sodium taurocholate cotransporting polypeptide (NTCP) Enables Hepatitis B Virus Infection of Macaques. J. Med. Primatol. 47, 324-324 (2018)
12.
Chou, W.M. et al.: Establishment and characterization of a novel recombinant reporter HBV utilizing the Cre-lox recombination system. J. Virol. 25, 37-37 (2018)
13.
Dembek, C.J. ; Protzer, U. & Roggendorf, M.: Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination. Curr. Opin. Virol. 30, 58-67 (2018)
14.
Esser, K. et al.: Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle. Antiviral Res. 151, 4-7 (2018)
15.
Faure-Dupuy, S.* et al.: Characterization of pattern recognition receptor expression and functionality in liver primary cells and derived cell lines. J. Innate Immun. 10, 339–348 (2018)
16.
Festag, M. et al.: Evaluation of a fully human car for the treatment of hepatitis B virus infection in an immunocompetent mouse model. Hum. Gene Ther. 29, A4-A4 (2018)
17.
Feuerherd, M. et al.: Altered HBV-specific CD4+T-cell Responses in HBV/HIV-1 Co-versus HBV Mono-infected Patients. J. Virol. 25, 52-53 (2018)
18.
Gehring, A.* & Protzer, U.: Targeting innate and adaptive immune responses to cure chronic HBV infection. Gastroenterology 156, 325-337 (2018)
19.
Karimzadeh, H. et al.: Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells. J. Virol. 92:13 e01891-17 (2018)
20.
Ko, C. et al.: Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. J. Hepatol. 69, 1231-1241 (2018)